Press Releases

MinervaX announces investment of 4.4 mEUR

MinervaX announces award of 4.4 million euro in investment from Novo Holding's repair impact fund and Sunstone Life Science Ventures for further clinical development of the company's vaccine against...

read more

Initiation of Phase I clinical trial

MinervaX initiates phase I clinical trial with innovative Group B Streptococcal (GBS) vaccine to prevent life-threatening infections in newborns. Novel, single component vaccine predicted to protect...

read more

Equity and Loan Financing

Group B Streptococcal vaccine for the prevention of life-threatening infections in newborns secures funding to reach clinical proof of concept. MinervaX, a privately held Danish biotech company,...

read more
Press Release